The Effect of Nitroprusside on Intrauterine Device (IUD) Insertion
Completed · Not applicable · Has a placebo group
Conditions studied: Cervical Pain, Pelvic Pain
In brief
Increasing accessibility of long-acting reversible contraceptive methods, like intrauterine devices (IUDs), is an important strategy to reduce the risk of unintended pregnancy. Unfortunately, fear of IUD insertion in women who have not had children is common among health care providers and women alike, and this limits IUD use. To increase acceptance of this highly effective contraceptive, there is need to investigate novel, low cost, easily applied and accessible techniques to improve the insertion experience. This is a pilot study to evaluate the efficacy and tolerability of nitroprusside gel applied intracervically as an intervention to improve the IUD insertion experience for both patient and provider.
Key facts
- Study ID
- NCT01248091
- Run by
- Oregon Health and Science University
- People needed
- 24
- Starts
- 2010-12-01
- Expected to finish
- 2011-07-01
- Last updated by the study team
- 2012-09-14
Who can join
Age: 18 and older, up to 45. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- age 18-45,
- Generally Healthy.
- requesting LNG-IUS for contraception as the primary indication
You may not qualify if…
- previous pregnancy beyond 20 weeks,
- previous IUD placement or attempted placement,
- allergy to nitroprusside,
- history of migraines,
- history of heart disease.
Where it is running
- Oregon Health and Science University — Portland, Oregon, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.